A Weynants1, L Goossens1, M Genetello2, D De Looze3, M Van Winckel2. 1. Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. 2. Department of Pediatric Gastroenterology, Ghent University Hospital, Ghent, Belgium. 3. Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium.
Abstract
BACKGROUND: Short-term trials with a low-FODMAP (fermentable oligosaccharides disaccharides monosaccharides and polyols) diet (LFD) show promising results in the symptomatic management of irritable bowel syndrome (IBS). The present study investigated the long-term adherence to an LFD diet, factors associated with adherence, and associations between LFD and quality of life (QOL), IBS symptoms and disease course on a long-term basis. METHODS: A retrospective cross-sectional study was conducted. Two hundred and thirty-four patients were enrolled from Ghent University hospital. Health-related QOL, long-term adherence to the LFD, disease course and IBS symptoms were assessed using a validated and self-developed questionnaire. RESULTS: Ninety (38.5%) patients completed the questionnaires. The median time span between the first dietary consultation and completion of the questionnaires was 99.5 weeks (approaching 2 years). The predominant disease course was mild IBS with an indolent course (43.0%). Eighty percent reported still following a diet in which certain FODMAP-rich food types are avoided. Eighty patients (88.9%) were satisfied that they follow or had followed the diet. The IBS-QOL did not differ between patients following the diet strictly and patients deviating from the diet (P = 0.669). Patients still following the LFD experienced less severe abdominal pain than patients who stopped following the diet (P = 0.044). CONCLUSIONS: The long-term adherence and satisfaction with the LFD is high in patients with IBS. Nevertheless, patients indicated that it was difficult to follow the LFD in daily life. Practical issues, social factors and the absence of symptoms were indicated as the main reasons for a drop in adherence.
BACKGROUND: Short-term trials with a low-FODMAP (fermentable oligosaccharides disaccharides monosaccharides and polyols) diet (LFD) show promising results in the symptomatic management of irritable bowel syndrome (IBS). The present study investigated the long-term adherence to an LFD diet, factors associated with adherence, and associations between LFD and quality of life (QOL), IBS symptoms and disease course on a long-term basis. METHODS: A retrospective cross-sectional study was conducted. Two hundred and thirty-four patients were enrolled from Ghent University hospital. Health-related QOL, long-term adherence to the LFD, disease course and IBS symptoms were assessed using a validated and self-developed questionnaire. RESULTS: Ninety (38.5%) patients completed the questionnaires. The median time span between the first dietary consultation and completion of the questionnaires was 99.5 weeks (approaching 2 years). The predominant disease course was mild IBS with an indolent course (43.0%). Eighty percent reported still following a diet in which certain FODMAP-rich food types are avoided. Eighty patients (88.9%) were satisfied that they follow or had followed the diet. The IBS-QOL did not differ between patients following the diet strictly and patients deviating from the diet (P = 0.669). Patients still following the LFD experienced less severe abdominal pain than patients who stopped following the diet (P = 0.044). CONCLUSIONS: The long-term adherence and satisfaction with the LFD is high in patients with IBS. Nevertheless, patients indicated that it was difficult to follow the LFD in daily life. Practical issues, social factors and the absence of symptoms were indicated as the main reasons for a drop in adherence.
Authors: Dorit Vedel Ankersen; Petra Weimers; Mette Bennedsen; Anne Birgitte Haaber; Eva Lund Fjordside; Moritz Emanuel Beber; Christian Lieven; Sanaz Saboori; Nicolai Vad; Terje Rannem; Dorte Marker; Kristine Paridaens; Suzanne Frahm; Lisbeth Jensen; Malte Rosager Hansen; Johan Burisch; Pia Munkholm Journal: J Med Internet Res Date: 2021-12-14 Impact factor: 5.428
Authors: A Rej; A Avery; I Aziz; C J Black; R K Bowyer; R L Buckle; L Seamark; C C Shaw; J Thompson; N Trott; M Williams; D S Sanders Journal: BMC Med Date: 2022-09-13 Impact factor: 11.150
Authors: Florencia Carbone; Karen Van den Houte; Linde Besard; Céline Tack; Joris Arts; Philip Caenepeel; Hubert Piessevaux; Alain Vandenberghe; Christophe Matthys; Jessica Biesiekierski; Luc Capiau; Steven Ceulemans; Olivier Gernay; Lydia Jones; Sophie Maes; Christian Peetermans; Willem Raat; Jeroen Stubbe; Rudy Van Boxstael; Olivia Vandeput; Sophie Van Steenbergen; Lukas Van Oudenhove; Tim Vanuytsel; Michael Jones; Jan Tack Journal: Gut Date: 2022-04-28 Impact factor: 31.793
Authors: Massimo Bellini; Sara Tonarelli; Attila G Nagy; Andrea Pancetti; Francesco Costa; Angelo Ricchiuti; Nicola de Bortoli; Marta Mosca; Santino Marchi; Alessandra Rossi Journal: Nutrients Date: 2020-01-04 Impact factor: 5.717